Top Tech Companies (2,068)
Don't see your company?
Create a company profile
GeneLink engages in genetic profile development, product development, business development, and support services.
Avammune Therapeutics is a drug discovery company.
Bioquark’s core program focuses on developing a novel class of substances termed combinatorial biologics,
Philadelphia-based biotechnology company .
FMC Corporation is an US-based chemical manufacturing company producing solutions for the agricultural, textile, and healthcare industries. FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC’s innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers, crop advisers and turf and pest management professionals to address their toughest challenges economically without compromising safety or the environment. With approximately 6,400 employees at more than 100 sites worldwide, FMC is committed to discovering new herbicide, insecticide and fungicide active ingredients, product formulations and pioneering technologies that are consistently better for the planet. Visit fmc.com to learn more.
Jenrin Discovery is a biopharmaceutical Company.
NexusPharma is dedicated to the discovery of novel therapeutics.
Bringing Speed and Certainty to Life Sciences
RiboMed Biotechnologies is a molecular diagnostic company.
Complexa, a biopharmaceutical company, develops therapies for the treatment of inflammatory, and metabolic diseases.
Immunetrics takes a Quantitative Systems Pharmacology (QSP) approach to creating mechanistic mathematical models of biological systems, accelerating development of drugs, clinical diagnostics, and medical/commercial devices. We predict FDA-approved endpoints through in silico clinical trial simulations of acute or chronic inflammatory diseases. We deliver proprietary mathematical models encompassing biological pathways and interactions that span levels of detail from intracellular signaling pathways, cell-cell interactions, and organ systems. We also utilize complex analyses to help better understand your data and create novel hypotheses. Our robust bio-simulation platform represents 10+ years of work by our team of experts. Our capabilities allow our clients to bring their health care solutions to market more quickly, at a lower cost, and with decreased risk. Immunetrics was founded in 2001 and collaborates regularly with the most significant names in drug development, medical devices, and academia. Our team includes a cross disciplinary group of experts in physiology, molecular biology, immunology, computational biology, machine learning, and software engineering in a highly collaborative environment. We provide the expertise and experience to build functional models to inform our clients in their decision making process. Immunetrics' offices and computing center are conveniently located in South Side of Pittsburgh, PA. Our city is the home of the University of Pittsburgh Medical Center, with its world-class Critical Care Medicine, Surgery and Immunology departments; Carnegie Mellon University, with its world-renowned Engineering and Mathematics groups; and the Pittsburgh Supercomputing Center.
Nova Analytic Labs is a unique comprehensive laboratory specializing in quality science, medicine and research in the Cannabis Community.
Please note that this company page is no longer updated. Meet us at https://www.linkedin.com/company/bio-rad-antibodies. As of May 17 2016, AbD Serotec, a Bio-Rad company changed its name to Bio-Rad. Following this re-branding, we created a new LinkedIn showcase page that features all the latest news, updates and useful resources from the antibody team at Bio-Rad. Please follow us on this new page (https://www.linkedin.com/company/bio-rad-antibodies) to keep in touch with us on LinkedIn.
AgBiome discovers and develops innovative biological and trait products for crop protection.
Glycan Therapeutics develops drug therapies based on a novel synthetic carbohydrate technology platform.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Pioneering Diagnostics A world leader in the field of in vitro diagnostics for over 55 years, bioMérieux is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock market.
Johns Hopkins Medicine is a governing structure for the University’s School of Medicine and the health system, coordinating their research, teaching, patient care, and related enterprises. The Johns Hopkins Hospital opened in 1889, followed four years later by the university’s School of Medicine, revolutionizing medical practice, teaching, and research in the United States. The hospital is now part of the Johns Hopkins Health System, which includes two other acute-care hospitals and additional integrated health-care delivery components, with a network of primary and specialty care practices throughout Maryland, outpatient care, long-term care, and home care. The Johns Hopkins University opened in 1876 as America’s first research university, founded for the express purpose of expanding knowledge and putting that knowledge to work for the good of humanity. Two Interconnected Institutions: Over the years, the University and Hospital have grown, and—sometimes jointly, sometimes separately—they have created affiliated organizations. The Johns Hopkins Institutions is a collective name for the University and the Johns Hopkins Health System. The Johns Hopkins University includes nine academic and research divisions, and numerous centers, institutes, and affiliated entities. Johns Hopkins Medicine is a governing structure for the University’s School of Medicine and the health system, coordinating their research, teaching, patient care, and related enterprises.
Unicity International, Inc. engages in the research, education, and development of new formulations for health and wellness. Unicity develops nutritional and personal care products and boasts 11 references in the Physician's Desk Reference guide for their cutting-edge, scientifically formulated products. The company offers Bios Life, a natural solution for cholesterol care. Unicity International was formerly known as Enrich International. Unicity International was founded in 2001 after the successful merger of Rexall Showcase International and Enrich International and is headquartered in Orem, Utah. Unicity is a global provider of products with offices in the United States, Canada, Venezuela, Colombia, Germany, Sweden, the United Kingdom, Japan, Korea, Taiwan, Hong Kong, the Philippines, Thailand, Malaysia, Singapore, Indonesia, Mexico, and Greater China.
We are a late-stage biopharmaceutical company focused on the development and commercialization of novel personalized therapeutics to treat cancer.
